Document
false--12-31Q220172017-07-020000078003Large Accelerated FilerPFEP9YP10YP3Y00.025P3Y4800000000P5Y150000000P9YP36M14807000000155060000006090000005790000000.0020.0420.010.00250000064100000045000000331000000265000000486000000422500000030720000005100000000 0000078003 2017-01-01 2017-07-02 0000078003 2017-08-07 0000078003 2016-01-01 2016-07-03 0000078003 2017-04-03 2017-07-02 0000078003 2016-04-04 2016-07-03 0000078003 pfe:LaboratorioTeutoBrasileroMember 2017-06-30 0000078003 2017-07-02 0000078003 2016-12-31 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-02-03 0000078003 2015-12-31 0000078003 2016-07-03 0000078003 pfe:AnacorMember 2016-06-24 0000078003 pfe:AccountingStandardsUpdate201609StatutoryTaxWithholdingComponentMember 2016-01-01 2016-07-03 0000078003 pfe:MedivationMember 2016-09-28 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-02-03 2017-02-03 0000078003 pfe:AstraZenecaMember 2016-12-22 2016-12-22 0000078003 pfe:AstraZenecaMember 2016-12-22 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2016-10-06 0000078003 pfe:MedivationMember 2016-12-31 0000078003 pfe:LaboratorioTeutoBrasileroMember pfe:LaboratorioTeutoBrasileroMember 2017-06-30 0000078003 pfe:BambooTherapeuticsMember 2016-08-01 0000078003 pfe:BambooTherapeuticsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-07-04 2016-10-02 0000078003 pfe:HisunPfizerPharmaceuticalsCoLtdMember 2016-04-04 2016-07-03 0000078003 pfe:BambooTherapeuticsMember 2017-01-01 2017-04-02 0000078003 pfe:BambooTherapeuticsMember 2016-08-01 2016-08-01 0000078003 pfe:AstraZenecaMember 2017-04-03 2017-07-02 0000078003 pfe:MerckKGaAMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:CollaborativeArrangementMember 2017-01-01 2017-07-02 0000078003 pfe:AnacorMember 2016-06-24 2016-06-24 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-01-01 2017-07-02 0000078003 pfe:MedivationMember 2016-09-28 2016-09-28 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember us-gaap:LondonInterbankOfferedRateLIBORMember 2017-02-03 2017-02-03 0000078003 pfe:HisunPfizerPharmaceuticalsCoLtdMember 2017-07-02 0000078003 pfe:LaboratorioTeutoBrasileroMember 2017-04-03 2017-07-02 0000078003 pfe:MedivationMember us-gaap:InProcessResearchAndDevelopmentMember 2016-09-28 0000078003 pfe:AstraZenecaMember us-gaap:MaximumMember 2016-12-22 2016-12-22 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-07-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember pfe:LaboratorioTeutoBrasileroMember 2016-01-01 2016-04-03 0000078003 pfe:AnacorMember us-gaap:InProcessResearchAndDevelopmentMember 2016-06-24 0000078003 pfe:HisunPfizerPharmaceuticalsCoLtdMember 2016-07-03 0000078003 pfe:AstraZenecaMember us-gaap:DevelopedTechnologyRightsMember 2016-12-22 0000078003 pfe:MedivationMember us-gaap:DevelopedTechnologyRightsMember 2016-09-28 0000078003 pfe:BambooTherapeuticsMember us-gaap:InProcessResearchAndDevelopmentMember 2016-08-01 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-04-03 2017-07-02 0000078003 pfe:AstraZenecaMember us-gaap:InProcessResearchAndDevelopmentMember 2016-12-22 0000078003 pfe:MedivationMember us-gaap:DevelopedTechnologyRightsMember 2016-09-28 2016-09-28 0000078003 pfe:AstraZenecaMember us-gaap:MinimumMember 2016-12-22 2016-12-22 0000078003 pfe:ICUMedicalMember us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember pfe:HISMember 2017-01-05 0000078003 pfe:HisunPfizerPharmaceuticalsCoLtdMember 2016-01-01 2016-04-03 0000078003 pfe:MerckKGaAMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:CollaborativeArrangementMember 2017-01-01 2017-04-02 0000078003 us-gaap:EmployeeSeveranceMember 2017-01-01 2017-07-02 0000078003 pfe:AssetImpairmentsMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherRestructuringMember 2017-01-01 2017-07-02 0000078003 us-gaap:EmployeeSeveranceMember 2017-07-02 0000078003 us-gaap:OtherRestructuringMember 2017-07-02 0000078003 us-gaap:EmployeeSeveranceMember 2016-12-31 0000078003 us-gaap:OtherRestructuringMember 2016-12-31 0000078003 pfe:AssetImpairmentsMember 2016-12-31 0000078003 pfe:AssetImpairmentsMember 2017-07-02 0000078003 us-gaap:OtherCurrentLiabilitiesMember 2017-07-02 0000078003 pfe:HospiraMember country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember 2017-07-02 0000078003 pfe:CentralizationofCorporateandPlatformFunctionsMember pfe:EnterprisewideCostReductionProductivityPlanMember 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:WorldwideResearchandDevelopmentandGlobalProductDevelopmentMember 2016-04-04 2016-07-03 0000078003 pfe:EnterprisewideCostReductionProductivityPlanMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember 2016-12-31 0000078003 pfe:HospiraMember pfe:ReturnofAcquiredRightsMember 2015-01-01 2015-12-31 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:ManufacturingOperationsMember 2017-04-03 2017-07-02 0000078003 pfe:EnterprisewideCostReductionProductivityPlanMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:HospiraMember us-gaap:ScenarioForecastMember 2015-09-03 2018-09-03 0000078003 us-gaap:CorporateNonSegmentMember 2017-04-03 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:BusinessIntegrationCostsMember 2017-01-01 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:WorldwideResearchandDevelopmentandGlobalProductDevelopmentMember 2017-01-01 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:ManufacturingOperationsMember 2016-04-04 2016-07-03 0000078003 pfe:ManufacturingPlantNetworkOptimizationMember pfe:EnterprisewideCostReductionProductivityPlanMember 2017-07-02 0000078003 us-gaap:OtherCurrentLiabilitiesMember 2016-12-31 0000078003 us-gaap:OperatingSegmentsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 us-gaap:OperatingSegmentsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 us-gaap:OperatingSegmentsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:WorldwideResearchandDevelopmentandGlobalProductDevelopmentMember 2016-01-01 2016-07-03 0000078003 pfe:HospiraMember pfe:BusinessIntegrationCostsMember 2017-01-01 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:ManufacturingOperationsMember 2016-01-01 2016-07-03 0000078003 us-gaap:OperatingSegmentsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 us-gaap:CorporateNonSegmentMember 2017-01-01 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:ManufacturingOperationsMember 2017-01-01 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 us-gaap:OperatingSegmentsMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:WorldwideResearchandDevelopmentandGlobalProductDevelopmentMember 2017-04-03 2017-07-02 0000078003 us-gaap:CorporateNonSegmentMember 2016-04-04 2016-07-03 0000078003 us-gaap:CorporateNonSegmentMember 2016-01-01 2016-07-03 0000078003 us-gaap:CostOfSalesMember 2016-04-04 2016-07-03 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-04-04 2016-07-03 0000078003 us-gaap:CostOfSalesMember 2017-01-01 2017-07-02 0000078003 us-gaap:CostOfSalesMember 2017-04-03 2017-07-02 0000078003 pfe:OtherIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 pfe:OtherIncomeExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2017-04-03 2017-07-02 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-07-02 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:ResearchAndDevelopmentExpenseMember 2016-01-01 2016-07-03 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-01-01 2017-07-02 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2016-01-01 2016-07-03 0000078003 us-gaap:CostOfSalesMember 2016-01-01 2016-07-03 0000078003 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2017-04-03 2017-07-02 0000078003 pfe:OtherIncomeExpenseMember 2017-04-03 2017-07-02 0000078003 pfe:OtherIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 pfe:HospiraMember 2015-09-03 2015-09-03 0000078003 us-gaap:DistributionRightsMember 2016-01-01 2016-07-03 0000078003 pfe:LaboratorioTeutoBrasileroMember 2016-01-01 2016-07-03 0000078003 us-gaap:OperatingSegmentsMember pfe:ViivHealthcareLimitedMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2016-04-04 2016-07-03 0000078003 pfe:LaboratorioTeutoBrasileroMember 2016-07-03 0000078003 pfe:XtandiMember 2017-01-01 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember pfe:ViivHealthcareLimitedMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:XtandiMember 2017-04-03 2017-07-02 0000078003 us-gaap:PendingLitigationMember pfe:ProductSafetyMisrepresentationMember pfe:CelebrexandBextraMember 2016-04-04 2016-07-03 0000078003 pfe:EnbrelMember us-gaap:CollaborativeArrangementCopromotionMember 2017-04-03 2017-07-02 0000078003 us-gaap:DevelopedTechnologyRightsMember 2016-04-04 2016-07-03 0000078003 pfe:EnbrelMember us-gaap:CollaborativeArrangementCopromotionMember 2017-01-01 2017-07-02 0000078003 pfe:HisunPfizerPharmaceuticalsCoLtdMember 2016-01-01 2016-07-03 0000078003 us-gaap:DistributionRightsMember 2017-01-01 2017-07-02 0000078003 pfe:HospiraMember us-gaap:OperatingSegmentsMember pfe:OtherInProcessResearchandDevelopmentMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 us-gaap:DistributionRightsMember 2017-04-03 2017-07-02 0000078003 pfe:HospiraMember us-gaap:OperatingSegmentsMember pfe:OtherInProcessResearchandDevelopmentMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 us-gaap:PendingLitigationMember pfe:ProductSafetyMisrepresentationMember pfe:CelebrexandBextraMember 2016-01-01 2016-07-03 0000078003 us-gaap:DevelopedTechnologyRightsMember 2016-01-01 2016-07-03 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2016-01-01 2016-07-03 0000078003 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-01-01 2017-07-02 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2016-12-31 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2016-12-31 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2017-07-02 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-07-02 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-07-02 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2017-07-02 0000078003 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2016-12-31 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2016-12-31 0000078003 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2016-12-31 0000078003 us-gaap:AccumulatedTranslationAdjustmentMember 2017-01-01 2017-07-02 0000078003 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2017-01-01 2017-07-02 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2017-07-02 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2017-07-02 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetPriorServiceCostCreditMember 2017-01-01 2017-07-02 0000078003 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentNetUnamortizedGainLossMember 2017-01-01 2017-07-02 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:OtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-03 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-03 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-03 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:CurrencySwapMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 pfe:ForeignCurrencyLongTermDebtMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2017-04-03 2017-07-02 0000078003 us-gaap:OtherNonoperatingIncomeExpenseMember 2017-01-01 2017-07-02 0000078003 pfe:ForeignCurrencyShortTermBorrowingsMember pfe:NetInvestmentHedgingNonderivativeInstrumentsMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NondesignatedMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:CurrencySwapMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:OtherComprehensiveIncomeMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:OtherComprehensiveIncomeMember 2017-04-03 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherComprehensiveIncomeMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherNonoperatingIncomeExpenseMember 2016-04-04 2016-07-03 0000078003 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2017-07-02 0000078003 us-gaap:ShortTermDebtMember 2016-12-31 0000078003 us-gaap:LongTermDebtMember 2017-07-02 0000078003 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2017-07-02 0000078003 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2017-07-02 0000078003 us-gaap:FairValueMeasurementsRecurringMember 2017-07-02 0000078003 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2016-12-31 0000078003 us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:ShortTermDebtMember 2017-07-02 0000078003 us-gaap:EquitySecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-07-02 0000078003 us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2017-07-02 0000078003 us-gaap:LongTermDebtMember 2016-12-31 0000078003 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:DebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 us-gaap:DebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2017-07-02 0000078003 us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2016-12-31 0000078003 pfe:LongtermInvestmentsMember 2017-07-02 0000078003 us-gaap:OtherNoncurrentAssetsMember 2017-07-02 0000078003 us-gaap:OtherCurrentAssetsMember 2016-12-31 0000078003 us-gaap:ShortTermInvestmentsMember 2017-07-02 0000078003 us-gaap:LongTermDebtMember 2016-12-31 0000078003 pfe:LongtermInvestmentsMember 2016-12-31 0000078003 pfe:ShortTermDebtAndCurrentPortionofLongTermDebtMember 2017-07-02 0000078003 us-gaap:ShortTermInvestmentsMember 2016-12-31 0000078003 pfe:ShortTermDebtAndCurrentPortionofLongTermDebtMember 2016-12-31 0000078003 us-gaap:LongTermDebtMember 2017-07-02 0000078003 us-gaap:CashAndCashEquivalentsMember 2016-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember 2016-12-31 0000078003 us-gaap:CashAndCashEquivalentsMember 2017-07-02 0000078003 us-gaap:OtherCurrentAssetsMember 2017-07-02 0000078003 pfe:EuroLongtermDebtMember us-gaap:SeniorNotesMember 2017-07-02 0000078003 us-gaap:CommercialPaperMember 2017-07-02 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2017-07-02 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2017-07-02 0000078003 us-gaap:InterestRateContractMember 2017-07-02 0000078003 us-gaap:TechnologySectorMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember 2016-12-31 0000078003 us-gaap:SeniorNotesMember us-gaap:MaximumMember pfe:GermanGovernmentBondRateMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2017-07-02 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember 2016-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember 2017-07-02 0000078003 us-gaap:UnsecuredDebtMember 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2016-12-31 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2017-07-02 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember pfe:ForeignCurrencyLongTermDebtMember 2017-07-02 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2017-07-02 0000078003 us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember 2017-07-02 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:InterestRateSwapMember 2016-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember 2017-07-02 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeForwardMember 2016-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2017-07-02 0000078003 us-gaap:SeniorNotesMember 2017-04-02 0000078003 us-gaap:FinancialServicesSectorMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignExchangeForwardMember 2017-07-02 0000078003 pfe:BesponsaMember 2017-06-30 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:CurrencySwapMember 2017-07-02 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2016-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:CurrencySwapMember 2017-07-02 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:InterestRateSwapMember 2016-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2016-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember 2016-12-31 0000078003 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2016-12-31 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember 2017-07-02 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:InterestRateSwapMember 2017-07-02 0000078003 pfe:EnergySectorMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeForwardMember 2016-12-31 0000078003 us-gaap:OtherCurrentAssetsMember us-gaap:CurrencySwapMember 2017-07-02 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2016-12-31 0000078003 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2017-07-02 0000078003 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:DevelopedTechnologyRightsMember pfe:BesponsaMember 2017-07-02 0000078003 us-gaap:OtherCurrentLiabilitiesMember us-gaap:CurrencySwapMember 2016-12-31 0000078003 us-gaap:CurrencySwapMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:NondesignatedMember 2016-12-31 0000078003 us-gaap:CommercialPaperMember 2016-12-31 0000078003 us-gaap:CorporateDebtSecuritiesMember 2017-07-02 0000078003 pfe:WesternEuropeanAsianandOtherGovernmentDebtMember 2017-07-02 0000078003 us-gaap:USGovernmentDebtSecuritiesMember 2017-07-02 0000078003 pfe:WesternEuropeanScandinaviaAndOtherGovernmentAgencyDebtMember 2017-07-02 0000078003 us-gaap:GovernmentNationalMortgageAssociationCertificatesAndObligationsGNMAMember 2017-07-02 0000078003 pfe:WesternEuropeanandOtherGovernmentDebtMember 2017-07-02 0000078003 us-gaap:AssetBackedSecuritiesMember 2017-07-02 0000078003 pfe:TimeDepositsCorporateDebtAndOtherMember 2017-07-02 0000078003 pfe:SupranationalDebtMember 2017-07-02 0000078003 pfe:SeniorUnsecuredEuroDebtZeroPercentDue2020Member us-gaap:SeniorNotesMember 2017-07-02 0000078003 pfe:SeniorUnsecuredEuroDebtOnePointZeroPercentDue2027Member us-gaap:SeniorNotesMember 2017-07-02 0000078003 pfe:SeniorUnsecuredDebtFourPointTwoPercentDue2047Member us-gaap:SeniorNotesMember 2017-07-02 0000078003 pfe:SeniorUnsecuredEuroDebtThreemonthEURIBORPlus0.20FloatingRateNotesMember us-gaap:SeniorNotesMember 2017-07-02 0000078003 us-gaap:SeniorNotesMember 2017-07-02 0000078003 pfe:SeniorUnsecuredEuroDebtPointTwofivePercentDue2022Member us-gaap:SeniorNotesMember 2017-07-02 0000078003 pfe:SeniorUnsecuredEuroDebtThreemonthEURIBORPlus0.20FloatingRateNotesMember us-gaap:SeniorNotesMember pfe:EURIBORMember 2017-01-01 2017-07-02 0000078003 2016-01-01 2016-12-31 0000078003 pfe:BesponsaMember 2017-06-01 2017-06-30 0000078003 us-gaap:DevelopedTechnologyRightsMember 2016-12-31 0000078003 us-gaap:TradeNamesMember 2016-12-31 0000078003 pfe:LicensingAgreementsAndOtherMember 2016-12-31 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2016-12-31 0000078003 us-gaap:DevelopedTechnologyRightsMember 2017-07-02 0000078003 us-gaap:InProcessResearchAndDevelopmentMember 2017-07-02 0000078003 us-gaap:TradeNamesMember 2017-07-02 0000078003 us-gaap:TradeNamesMember 2016-12-31 0000078003 pfe:LicensingAgreementsAndOtherMember 2017-07-02 0000078003 us-gaap:TradeNamesMember 2017-07-02 0000078003 pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthSegmentMember 2017-07-02 0000078003 pfe:InnovativeHealthSegmentMember 2016-12-31 0000078003 pfe:EssentialHealthSegmentMember 2016-12-31 0000078003 pfe:InnovativeHealthSegmentMember 2017-07-02 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2017-04-03 2017-07-02 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2016-04-04 2016-07-03 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2017-01-01 2017-07-02 0000078003 us-gaap:FiniteLivedIntangibleAssetsMember 2016-01-01 2016-07-03 0000078003 us-gaap:InProcessResearchAndDevelopmentMember pfe:EucrisaMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:EssentialHealthSegmentMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:EssentialHealthSegmentMember 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:DevelopedTechnologyRightsMember pfe:PfizersWorldwideResearchandDevelopmentMember 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:TradeNamesMember pfe:PfizersWorldwideResearchandDevelopmentMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember us-gaap:DevelopedTechnologyRightsMember pfe:InnovativeHealthSegmentMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:EssentialHealthSegmentMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:InnovativeHealthSegmentMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:InnovativeHealthSegmentMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember us-gaap:TradeNamesMember pfe:EssentialHealthSegmentMember 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:InnovativeHealthSegmentMember 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:TradeNamesMember pfe:PfizersWorldwideResearchandDevelopmentMember 2017-07-02 0000078003 us-gaap:MaterialReconcilingItemsMember us-gaap:InProcessResearchAndDevelopmentMember pfe:PfizersWorldwideResearchandDevelopmentMember 2017-07-02 0000078003 us-gaap:DevelopedTechnologyRightsMember pfe:EucrisaMember 2017-07-02 0000078003 pfe:HospiraMember country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-04-01 2017-04-30 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-01-31 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-07-02 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-01-01 2017-07-02 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-07-02 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-07-02 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2017-07-02 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2017-01-01 2017-07-02 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-01-01 2016-07-03 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-04-03 2017-07-02 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2017-04-03 2017-07-02 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-04-04 2016-07-03 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-01-01 2016-07-03 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2017-04-03 2017-07-02 0000078003 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2016-01-01 2016-07-03 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2016-04-04 2016-07-03 0000078003 country:US us-gaap:NonqualifiedPlanMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2016-01-01 2016-07-03 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2017-04-03 2017-07-02 0000078003 country:US us-gaap:QualifiedPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-04-04 2016-07-03 0000078003 us-gaap:ForeignPlanMember us-gaap:PensionPlansDefinedBenefitMember 2016-04-04 2016-07-03 0000078003 us-gaap:StockOptionMember 2016-04-04 2016-07-03 0000078003 us-gaap:StockOptionMember 2017-01-01 2017-07-02 0000078003 us-gaap:StockOptionMember 2016-01-01 2016-07-03 0000078003 us-gaap:StockOptionMember 2017-04-03 2017-07-02 0000078003 pfe:PfizerVersusBMSE.R.SquibbSonsOnoPharmaceuticalandTasukuHonjoMember us-gaap:PendingLitigationMember pfe:PatentInfringementMember pfe:BavencioMember us-gaap:SubsequentEventMember 2017-07-01 2017-07-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusPrinstonandBreckenridgeMember us-gaap:PendingLitigationMember pfe:XeljanzMember 2017-03-01 2017-03-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazMember 2016-07-01 2016-07-31 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-06 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusZydusMember us-gaap:PendingLitigationMember pfe:XeljanzMember 2017-03-01 2017-03-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:JudicialRulingMember pfe:ToviazMember 2017-02-01 2017-02-28 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-02 2017-02-02 0000078003 pfe:PatentInfringementMember pfe:PfizerandBMSVersusSeveralGenericManufacturersMember us-gaap:PendingLitigationMember pfe:EliquisMember 2017-02-01 2017-04-30 0000078003 pfe:HospiraVersusFreseniusMember us-gaap:PendingLitigationMember pfe:PrecedexPremixMember 2015-12-01 2015-12-31 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-06 2017-05-19 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusSeveralGenericManufacturersMember us-gaap:PendingLitigationMember pfe:ToviazCompositionofmatterPatentsMember 2013-06-01 2013-06-30 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:JudicialRulingMember pfe:ToviazMember us-gaap:SubsequentEventMember 2017-08-01 2017-08-10 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazMember 2015-01-01 2015-01-31 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-02 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member us-gaap:PendingLitigationMember pfe:InflectraMember 2015-03-01 2015-03-31 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member us-gaap:SettledLitigationMember pfe:InflectraMember 2015-03-01 2015-03-31 0000078003 pfe:EnvironmentalRemediationLitigationMember 2013-03-01 2013-03-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazCompositionofmatterPatentsMember 2016-01-01 2016-01-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMicroLabsMember us-gaap:PendingLitigationMember pfe:XeljanzMember 2017-02-01 2017-02-28 0000078003 pfe:HospiraVersusAmnealPharmaceuticalsLLCMember us-gaap:PendingLitigationMember pfe:PrecedexPremixMember 2015-06-01 2015-06-30 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-07-02 0000078003 pfe:ViolationofAntitrustLawsMember pfe:PhenytoinSodiumCapsulesMember 2016-12-01 2016-12-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazMember 2016-01-01 2016-01-31 0000078003 pfe:RegentsVersusMedivationMember us-gaap:SettledLitigationMember pfe:XtandiMember 2017-04-01 2017-04-30 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazCompositionofmatterPatentsMember 2015-01-01 2015-01-31 0000078003 pfe:StateofIllinoisVersusPfizerMember us-gaap:PendingLitigationMember pfe:AverageWholesalePriceMember 2017-07-02 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusSeveralGenericManufacturersMember us-gaap:SettledLitigationMember pfe:ToviazMember 2015-06-01 2015-07-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:JudicialRulingMember pfe:ToviazMember us-gaap:SubsequentEventMember 2017-07-01 2017-07-31 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-02-06 2017-02-06 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusSeveralGenericManufacturersMember us-gaap:PendingLitigationMember pfe:ToviazMember 2015-07-01 2015-07-31 0000078003 pfe:ShareRepurchaseAgreementwithCitibankMember 2017-05-19 2017-05-19 0000078003 pfe:HospiraVersusParMember us-gaap:PendingLitigationMember pfe:PrecedexPremixMember 2016-08-01 2016-08-31 0000078003 pfe:ClassActionVersusAmericanOpticalCorporationAndVariousOtherDefendantsMember us-gaap:PendingLitigationMember us-gaap:DamagesFromProductDefectsMember 2017-07-02 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:JudicialRulingMember pfe:ToviazMember 2017-01-01 2017-01-31 0000078003 pfe:JanssenandNewYorkUniversityVersusHospiraCelltrionHealthcareandCelltrionInc.Member pfe:InflectraMember 2015-03-01 2015-03-31 0000078003 pfe:PatentInfringementMember pfe:PfizerVersusMylanLaboratoriesandAccordHealthcareInc.Member us-gaap:PendingLitigationMember pfe:ToviazMember 2013-06-01 2013-06-30 0000078003 pfe:DevelopedEuropeMember 2017-01-01 2017-07-02 0000078003 pfe:EmergingMarketsMember 2017-01-01 2017-07-02 0000078003 pfe:DevelopedEuropeMember 2017-04-03 2017-07-02 0000078003 country:US 2017-04-03 2017-07-02 0000078003 country:US 2017-01-01 2017-07-02 0000078003 pfe:EmergingMarketsMember 2017-04-03 2017-07-02 0000078003 country:US 2016-04-04 2016-07-03 0000078003 pfe:DevelopedRestOfWorldMember 2016-01-01 2016-07-03 0000078003 pfe:DevelopedRestOfWorldMember 2017-04-03 2017-07-02 0000078003 pfe:DevelopedEuropeMember 2016-01-01 2016-07-03 0000078003 pfe:DevelopedRestOfWorldMember 2017-01-01 2017-07-02 0000078003 pfe:DevelopedEuropeMember 2016-04-04 2016-07-03 0000078003 pfe:EmergingMarketsMember 2016-04-04 2016-07-03 0000078003 pfe:EmergingMarketsMember 2016-01-01 2016-07-03 0000078003 pfe:DevelopedRestOfWorldMember 2016-04-04 2016-07-03 0000078003 country:US 2016-01-01 2016-07-03 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember 2017-01-01 2017-07-02 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-07-03 0000078003 pfe:OtherUnallocatedMember us-gaap:MaterialReconcilingItemsMember 2017-04-03 2017-07-02 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-07-02 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2017-04-03 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember 2017-04-03 2017-07-02 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2017-04-03 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember 2016-04-04 2016-07-03 0000078003 pfe:OtherUnallocatedMember us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-07-03 0000078003 us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-07-02 0000078003 us-gaap:OperatingSegmentsMember 2016-01-01 2016-07-03 0000078003 us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-07-03 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2016-04-04 2016-07-03 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2016-04-04 2016-07-03 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2016-04-04 2016-07-03 0000078003 us-gaap:MaterialReconcilingItemsMember 2016-04-04 2016-07-03 0000078003 us-gaap:MaterialReconcilingItemsMember 2017-04-03 2017-07-02 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-07-03 0000078003 pfe:BusinessCombinationsAcquisitionRelatedCostsMember us-gaap:MaterialReconcilingItemsMember 2016-01-01 2016-07-03 0000078003 pfe:CertainSignificantItemsMember us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-07-02 0000078003 pfe:OtherUnallocatedMember us-gaap:MaterialReconcilingItemsMember 2016-04-04 2016-07-03 0000078003 pfe:PurchaseAccountingAdjustmentsMember us-gaap:MaterialReconcilingItemsMember 2017-04-03 2017-07-02 0000078003 pfe:OtherUnallocatedMember us-gaap:MaterialReconcilingItemsMember 2017-01-01 2017-07-02 0000078003 currency:EUR pfe:DevelopedEuropeMember 2016-01-01 2016-07-03 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:HISMember 2017-04-03 2017-07-02 0000078003 us-gaap:CorporateNonSegmentMember us-gaap:ScenarioAdjustmentMember 2016-01-01 2016-07-03 0000078003 us-gaap:MaterialReconcilingItemsMember pfe:HISMember 2017-01-01 2017-07-02 0000078003 currency:EUR pfe:DevelopedEuropeMember 2017-04-03 2017-07-02 0000078003 currency:EUR pfe:DevelopedEuropeMember 2016-04-04 2016-07-03 0000078003 us-gaap:CorporateNonSegmentMember us-gaap:ScenarioAdjustmentMember 2016-04-04 2016-07-03 0000078003 currency:EUR pfe:DevelopedEuropeMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:FragminMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:InflectraRemsimaMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:AllOtherRareDiseaseProductsMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:RelpaxMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:LyricaMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XalkoriMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:SomavertMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZithromaxZmaxMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EucrisaMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:CelebrexMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XtandiAllianceMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ViagraMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:OtherLegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:TygacilMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EffexorMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XanaxXanaxXRMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZoloftMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:BosulifMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:SomavertMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:EliquisMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:LyricaMember pfe:InnovativeHealthandEssentialHealthMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:GenotropinMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:RelpaxMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:NorvascMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:ConsumerHealthcareMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:OtherOncologyProductsMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:FragminMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:LyricaMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ChantixChampixMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:PremarinFamilyMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:ConsumerHealthcareMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:ViagraMember pfe:InnovativeHealthandEssentialHealthMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ViagraMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ToviazMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XalkoriMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EnbrelMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:IbranceMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:HospiraInfusionSystemsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EpiPenMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:AllOtherInflammationandImmunologyProductsMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InlytaMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EffexorMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZoloftMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:TygacilMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XalatanXalacomMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:IbranceMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZoloftMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InlytaMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:ConsumerHealthcareMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:NorvascMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ViagraMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:PremarinFamilyMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:CelebrexMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XalatanXalacomMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:VfendMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:BosulifMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:BMP2Member pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:FSMEIMMUNTicoVacMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:AllianceBiopharmaceuticalsMember pfe:InnovativeHealthandEssentialHealthMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:AllOtherPeriLOEProductsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthandEssentialHealthMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:BosulifMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:OtherVaccinesProductsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:AllOtherInflammationandImmunologyProductsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:BeneFIXMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:SulperazonMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InlytaMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:BosulifMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:FragminMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EpiPenMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:OtherLegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:PrecedexMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:LyricaMember pfe:InnovativeHealthandEssentialHealthMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:CelebrexMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:PrevnarPrevenarFamilyMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:MedrolMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:TygacilMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:AllOtherInternalMedicineMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:LyricaMember pfe:InnovativeHealthandEssentialHealthMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XtandiAllianceMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:VfendMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ViagraMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:AllOtherBiosimilarsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ZyvoxMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EffexorMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XalatanXalacomMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:LipitorMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:RelpaxMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ViagraMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:AllOtherInflammationandImmunologyProductsMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:AllOtherBiosimilarsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:RevatioMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:BMP2Member pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:AllOtherInternalMedicineMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EpiPenMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:XeljanzMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:PristiqMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XalkoriMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:EliquisMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ChantixChampixMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:HospiraInfusionSystemsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XanaxXanaxXRMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthandEssentialHealthMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:PrevnarPrevenarFamilyMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:AllOtherRareDiseaseProductsMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XalatanXalacomMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:EliquisMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ViagraMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:ReFactoAfXynthaMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:BeneFIXMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:AllOtherSterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:CelebrexMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:CentreOneMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:OtherVaccinesProductsMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:AllOtherPeriLOEProductsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:BMP2Member pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:LyricaMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:SutentMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:FSMEIMMUNTicoVacMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:AllOtherInternalMedicineMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:ReFactoAfXynthaMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:SulperazonMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:MedrolMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:OtherLegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:OtherOncologyProductsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:CentreOneMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:CentreOneMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XtandiAllianceMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:ConsumerHealthcareMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:PrecedexMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:MedrolMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:PristiqMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:LyricaMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:LyricaMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EnbrelMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:VfendMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:PristiqMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:ViagraMember pfe:InnovativeHealthandEssentialHealthMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:HospiraInfusionSystemsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XtandiAllianceMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:RevatioMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:XeljanzMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:InflectraRemsimaMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:AllOtherBiosimilarsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InlytaMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:NorvascMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:LipitorMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:PrecedexMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:FragminMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZoloftMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:LipitorMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:NorvascMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:InflectraRemsimaMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:AllOtherBiosimilarsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EucrisaMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:BiosimilarsMember pfe:InflectraRemsimaMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:IbranceMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:TygacilMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:SutentMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ZyvoxMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:AllianceBiopharmaceuticalsMember pfe:InnovativeHealthandEssentialHealthMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ZyvoxMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:OtherVaccinesProductsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZithromaxZmaxMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:PrevnarPrevenarFamilyMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:GenotropinMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:PremarinFamilyMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:BeneFIXMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:AllOtherRareDiseaseProductsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:FSMEIMMUNTicoVacMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:AllOtherInflammationandImmunologyProductsMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:XeljanzMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:FSMEIMMUNTicoVacMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EnbrelMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ViagraMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:PrevnarPrevenarFamilyMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XanaxXanaxXRMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:SomavertMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:RevatioMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:GenotropinMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ToviazMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ViagraMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:BeneFIXMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:AllOtherInternalMedicineMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EnbrelMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ToviazMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:AllOtherSterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:OtherOncologyProductsMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZithromaxZmaxMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EffexorMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:PristiqMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:AllOtherPeriLOEProductsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthandEssentialHealthMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:ZyvoxMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:LyricaMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:IbranceMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:ViagraMember pfe:InnovativeHealthandEssentialHealthMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthandEssentialHealthMember 2016-01-01 2016-07-03 0000078003 pfe:AllianceBiopharmaceuticalsMember pfe:InnovativeHealthandEssentialHealthMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:EliquisMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:OtherLegacyEstablishedProductsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ChantixChampixMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:AllianceBiopharmaceuticalsMember pfe:InnovativeHealthandEssentialHealthMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:PremarinFamilyMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:AllOtherRareDiseaseProductsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:ReFactoAfXynthaMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:ZithromaxZmaxMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:RelpaxMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:LyricaMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ChantixChampixMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:GenotropinMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:SulperazonMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:AllOtherSterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EucrisaMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:VfendMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:AllOtherPeriLOEProductsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:AllOtherSterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:XanaxXanaxXRMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:HospiraInfusionSystemsMember pfe:EssentialHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:MedrolMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:LipitorMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:SomavertMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:XeljanzMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:XalkoriMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:RareDiseaseMember pfe:ReFactoAfXynthaMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:OtherOncologyProductsMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:RevatioMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InflammationandImmunologyMember pfe:EucrisaMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:InnovativeHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:SulperazonMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:LegacyEstablishedProductsMember pfe:EpiPenMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:LyricaMember pfe:InnovativeHealthandEssentialHealthMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:CentreOneMember pfe:EssentialHealthSegmentMember 2017-01-01 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:VaccinesMember pfe:OtherVaccinesProductsMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:ToviazMember pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:SutentMember pfe:InnovativeHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:ViagraMember pfe:InnovativeHealthandEssentialHealthMember 2017-04-03 2017-07-02 0000078003 pfe:EssentialHealthBusinessMember pfe:SterileInjectablePharmaceuticalsMember pfe:PrecedexMember pfe:EssentialHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:OncologyMember pfe:SutentMember pfe:InnovativeHealthSegmentMember 2016-01-01 2016-07-03 0000078003 pfe:EssentialHealthBusinessMember pfe:PeriLOEProductsMember pfe:LyricaMember pfe:EssentialHealthSegmentMember 2016-04-04 2016-07-03 0000078003 pfe:InnovativeHealthBusinessMember pfe:InternalMedicineMember pfe:BMP2Member pfe:InnovativeHealthSegmentMember 2017-04-03 2017-07-02 xbrli:shares pfe:Operating_Segment xbrli:pure iso4217:USD iso4217:USD xbrli:shares iso4217:GBP pfe:Claim pfe:lagoon pfe:Patents pfe:Defendant iso4217:EUR
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q

X   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended July 2, 2017

OR

TRANSITION REPORT PURSUANT TO SECTION 13
OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

COMMISSION FILE NUMBER 1-3619

----

PFIZER INC.
(Exact name of registrant as specified in its charter)

DELAWARE
(State of Incorporation)
13-5315170
(I.R.S. Employer Identification No.)

235 East 42nd Street, New York, New York  10017
(Address of principal executive offices)  (zip code)
(212) 733-2323
(Registrant’s telephone number)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.
YES   X 
NO ___

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).
YES   X 
NO ___

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (check one):

Large Accelerated filer  X                 Accelerated filer  ___                  Non-accelerated filer  ___             Smaller reporting company  ___        Emerging growth company  ___

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ___

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
YES ____
NO   X 

At August 7, 2017, 5,947,349,054 shares of the issuer’s voting common stock were outstanding.


Table of Contents
Page
 
 
 
 
 
 
Condensed Consolidated Statements of Income for the three and six months ended July 2, 2017 and July 3, 2016
 
 
Condensed Consolidated Statements of Comprehensive Income for the three and six months ended July 2, 2017 and
July 3, 2016
 
 
Condensed Consolidated Balance Sheets as of July 2, 2017 and December 31, 2016
 
 
Condensed Consolidated Statements of Cash Flows for the six months ended July 2, 2017 and July 3, 2016